May 26, 2011 - D3 Oncology Solutions announced that it will provide its Via Oncology Pathways for a six-month free trial period to enable cancer programs to align the timing of their investment with a strategy for sharing potential savings with payors and other key stakeholders.
Despite the widespread awareness of oncology pathways by oncologists today, the barriers to their adoption stem from a common set of issues confronting most oncology practices. Without the appropriate tools to evaluate historical physician treatment patterns, most practices are unable to project the impact of a pathways program on the cost of care, both to the payor and patient, as well as to the practice itself. In addition, the contracting vehicles for sharing value creation with health plans, accountable care organizations (ACOs), medical homes and referring physicians are difficult to achieve prior to actually implementing the pathways.
In response to these issues, D3 Oncology Solutions is offering accelerated implementation of a non-customized version of its Via Oncology Pathways program to oncology practices and health systems for a trial period of six months at no charge.
For more information: www.d3onc.com
July 11, 2024 
